“Tan Sheet” Participates In Capitol Hill Briefing On PSE Diversion
This article was originally published in The Tan Sheet
Executive Summary
“The Tan Sheet” moderates a briefing Acura hosted to inform congressional staff about the impact of its tamper-resistant single-ingredient Nexafed on PSE diversion and for Sen. Joe Manchin to discuss Rx drug abuse. The story includes a link to a video of the event.
You may also be interested in...
Hydrocodone Reclassification Could Benefit Long-Acting Opioids
FDA’s recommendation that combination hydrocodone products be moved to the more restrictive Schedule II will increase the regulatory burdens for physicians and pharmacies while making the already restricted extended-release oxycodone products relatively more appealing.
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.
US Health And Wellness People News: CHPA, Bayer, Viatris, Qnovia, Powerade
Sanofi consumer health scientific affairs lead moves to CHPA; change in Bayer’s US consumer health marketing helm; Viatris CCO moves from same post at Moderna; Qnovia expands scientific advisory board; and Powerade powers Girls Inc. scholarships, programs.